Nextgen Biomed Ltd (TLV:NXGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 54.90
+3.90 (7.10%)
May 13, 2025, 5:24 PM IDT
Nextgen Biomed Market Cap
Nextgen Biomed has a market cap or net worth of 6.34 million as of May 13, 2025. Its market cap has decreased by -25.67% in one year.
Market Cap
6.34M
Enterprise Value
6.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
54.90
Market Cap Chart
Since July 17, 2013, Nextgen Biomed's market cap has decreased from 18.97M to 6.34M, a decrease of -66.60%. That is a compound annual growth rate of -8.86%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.16B |
| Novolog (Pharm-Up 1966) | 774.95M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |